The Maternal Immune Activation Mouse Model of Autism Spectrum Disorders

The Maternal Immune Activation Mouse Model of Autism Spectrum Disorders

Show other versions (1)

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social interaction and communication as well as ritualistic repetitive behaviors. Epidemiological studies suggest that maternal immune activation (MIA) during pregnancy may be a risk factor for ASD. To st...

Full description

Bibliographic Details
Main Author:	Xuan, Ingrid Cong Yang
Other Authors:	Hampson, David R.
Language:	en_ca
Published:	2013
Subjects:	Autism Spectrum Disorder Fragile X Syndrome 0317
Online Access:	http://hdl.handle.net/1807/43346

Similar Items

The Maternal Immune Activation Mouse Model of Autism Spectrum Disorders
by: Xuan, Ingrid Cong Yang
Published: (2013)

High-functioning autism spectrum disorder and fragile X syndrome: report of two affected sisters
by: Chaste Pauline, et al.
Published: (2012-06-01)

Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans
by: Jinyoung Won, et al.
Published: (2017-06-01)

Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models
by: Polina Kosillo, et al.
Published: (2021-07-01)

Autism spectrum disorders: emerging mechanisms and mechanism-based treatment
by: Hansen eWang, et al.
Published: (2015-05-01)

Editorial: Secondary vs. Idiopathic Autism
by: Manuel F. Casanova, et al.
Published: (2020-04-01)

Screening for FMR1 expanded alleles in patients with Autism Spectrum Disorders in Manaus, Northern Brazil
by: JORGE F.B. FERREIRA, et al.

Adaptive Status, Autistic Symptoms and Cognitive Profile in Patients with Monogenic Form of Autism Spectrum Disorders – Fragile X Syndrome
by: Danilina K.K., et al.
Published: (2020-07-01)

Development of Experimental Protocol for Visual Cognitive Function Evaluation in Children with Autism Spectrum Disorders
by: Pereverzeva D.S.,, et al.
Published: (2016-10-01)

Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography—What Can be Interpreted from the Available Information?
by: Niamh Mc Devitt, et al.
Published: (2015-03-01)

5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders
by: Lucia eCiranna, et al.
Published: (2014-08-01)

Autism Spectrum Disorders
Published: (2021)

Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment
by: Akash Rajaratnam, et al.
Published: (2020-10-01)

Understanding intellectual disability and autism spectrum disorders from common mouse models: synapses to behaviour
by: Vijaya Verma, et al.
Published: (2019-06-01)

Autistic Spectrum Disorder
by: J Gordon Millichap
Published: (1988-10-01)

Transcranial magnetic stimulation provides means to assess cortical plasticity and excitability in humans with fragile X syndrome and autism spectrum disorder
by: Lindsay M Oberman, et al.
Published: (2010-06-01)

Developmental divergence: motor trajectories in children with fragile X syndrome with and without co-occurring autism
by: Elizabeth A. Will, et al.
Published: (2019-10-01)

<i>FMR1</i> and Autism, an Intriguing Connection Revisited
by: William Fyke, et al.
Published: (2021-08-01)

Channelopathy Pathogenesis in Autism Spectrum Disorders
by: Galina eSchmunk, et al.
Published: (2013-11-01)

Neural and Synaptic Defects in Autism Spectrum Disorders
Published: (2015)

Early negative affect in males and females with fragile X syndrome: implications for anxiety and autism
by: Carla A. Wall, et al.
Published: (2019-09-01)

Differential effects of anxiety and autism on social scene scanning in males with fragile X syndrome
by: Hayley Crawford, et al.
Published: (2017-09-01)

Autism spectrum disorder in females with fragile X syndrome: a systematic review and meta-analysis of prevalence
by: M. Marlborough, et al.
Published: (2021-07-01)

Epigenetic Regulations in Neuropsychiatric Disorders
by: Janise N. Kuehner, et al.
Published: (2019-04-01)

Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders
by: Michael Telias
Published: (2019-03-01)

Fragile X syndrome: Lessons learned from the most translated neurodevelopmental disorder in clinical trials
by: Duy Phan Q., et al.
Published: (2017-03-01)

Minor physical anomalies in autism spectrum disorders and velocardiofacial syndrome
by: Tang, Heung, Christina., et al.
Published: (2013)

White matter as a monitoring biomarker for neurodevelopmental disorder intervention studies
by: Meghan R. Swanson, et al.
Published: (2019-12-01)

Pervasive refusal syndrome in autism spectrum disorder: difficulties in diagnosis
by: U. R. Attygalle, et al.
Published: (2019-06-01)

New treatment perspectives in autism spectrum disorders
by: Roberto eCanitano, et al.
Published: (2015-03-01)

The fragile X syndrome-autism comorbidity: what do we really know?
by: Leonard eAbbeduto, et al.
Published: (2014-10-01)

Intellectual Disability and Autism Spectrum Disorders
by: Sorokin A.B.
Published: (2018-03-01)

Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
by: Hagberg KW, et al.
Published: (2018-11-01)

Children with autism spectrum disorders and selective mutism
by: Steffenburg H, et al.
Published: (2018-05-01)

Genome-wide expression studies in Autism spectrum disorder, Rett syndrome, and Down syndrome
by: Carla Lintas, et al.
Published: (2012-01-01)

Focusing on Autism Spectrum Disorder in Xia–Gibbs Syndrome: Description of a Female with High Functioning Autism and Literature Review
by: Stefania Della Vecchia, et al.
Published: (2021-05-01)

Physical activity levels of children with autism spectrum disorder
by: Johnson, Courtney P.
Published: (2012)

Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome
by: Debra L. Reisinger, et al.
Published: (2020-04-01)

Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome
by: Anke Van Dijck, et al.
Published: (2020-04-01)

Insulin-Like Growth Factor 1 and Related Compounds in the Treatment of Childhood-Onset Neurodevelopmental Disorders
by: Cyrus Vahdatpour, et al.
Published: (2016-09-01)